These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23723434)

  • 1. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.
    Busnelli M; Bulgheroni E; Manning M; Kleinau G; Chini B
    J Pharmacol Exp Ther; 2013 Aug; 346(2):318-27. PubMed ID: 23723434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
    Ingram CD; Tolchard S
    J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions.
    Song Z; Borland JM; Larkin TE; O'Malley M; Albers HE
    Psychoneuroendocrinology; 2016 Dec; 74():164-172. PubMed ID: 27632574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors.
    Song Z; McCann KE; McNeill JK; Larkin TE; Huhman KL; Albers HE
    Psychoneuroendocrinology; 2014 Dec; 50():14-9. PubMed ID: 25173438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor.
    Ramos L; Hicks C; Kevin R; Caminer A; Narlawar R; Kassiou M; McGregor IS
    Neuropsychopharmacology; 2013 Oct; 38(11):2249-59. PubMed ID: 23676791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.
    Braida D; Donzelli A; Martucci R; Capurro V; Busnelli M; Chini B; Sala M
    Psychopharmacology (Berl); 2012 Mar; 220(2):319-30. PubMed ID: 21956239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors.
    Terrillon S; Cheng LL; Stoev S; Mouillac B; Barberis C; Manning M; Durroux T
    J Med Chem; 2002 Jun; 45(12):2579-88. PubMed ID: 12036367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding affinities of oxytocin, vasopressin and Manning compound at oxytocin and V1a receptors in male Syrian hamster brains.
    Taylor JH; McCann KE; Ross AP; Albers HE
    J Neuroendocrinol; 2020 Jul; 32(7):e12882. PubMed ID: 32662552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor.
    Pierce ML; French JA; Murray TF
    Biomed Pharmacother; 2020 Jun; 126():110060. PubMed ID: 32145592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.
    Hicks C; Ramos L; Reekie T; Misagh GH; Narlawar R; Kassiou M; McGregor IS
    Br J Pharmacol; 2014 Jun; 171(11):2868-87. PubMed ID: 24641248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.
    Manning M; Misicka A; Olma A; Bankowski K; Stoev S; Chini B; Durroux T; Mouillac B; Corbani M; Guillon G
    J Neuroendocrinol; 2012 Apr; 24(4):609-28. PubMed ID: 22375852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
    Yibchok-anun S; Hsu WH
    Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacologic profiles of arginine vasopressin and oxytocin analogs at marmoset, titi monkey, macaque, and human oxytocin receptors.
    Pierce ML; French JA; Murray TF
    Biomed Pharmacother; 2020 May; 125():109832. PubMed ID: 32018219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin.
    Manning M; Sawyer WH
    J Recept Res; 1993; 13(1-4):195-214. PubMed ID: 8383753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM; Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1998 Mar; 69(2):136-46. PubMed ID: 9619993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus).
    Song Z; Larkin TE; Malley MO; Albers HE
    Horm Behav; 2016 May; 81():20-7. PubMed ID: 26975586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.
    Wolfe M; Wisniewska H; Tariga H; Ibanez G; Collins JC; Wisniewski K; Qi S; Srinivasan K; Hargrove D; Lindstrom BF
    Neuropeptides; 2018 Aug; 70():64-75. PubMed ID: 29807652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.